Insights On Drug Discovery
-
Translating Massive Data Into Therapeutic Momentum
3/13/2026
New advances in chemomics, proteome mapping, and modern synthetic methods are redefining how quickly and precisely discovery teams can move from raw data to meaningful clinical momentum.
-
ADCs: Overcoming Analytical Challenges In Next-Gen Cancer Therapies
2/24/2026
Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment. But with innovation comes complexity.
-
From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing
2/12/2026
As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.
-
The Science Of Cell Line Development For Biologics
2/12/2026
Selecting and engineering the right cell line is not simply a technical milestone; it is a strategic decision that shapes cost of goods, development timelines, and the overall probability of success.
-
The Gateway Delivery To The Brain
1/30/2026
Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.
-
Covalent Warhead Reactivity: A New Look At GSH Reactivity Assays
1/26/2026
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
Flow Chemistry For Contemporary Isotope Labeling
1/26/2026
Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications.
-
Optimizing Lentiviral Producer Cell Line Yield
12/15/2025
Producer cell lines boost lentiviral manufacturing efficiency via high-density culture, multiple harvests, and additive optimization for scalable production.
-
Patient-Centric Formulations In Pediatric Adherence
11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Scientific Poster: Driving High-Titer Productivity And Faster Timelines
11/13/2025
Accelerated cell line development delivers high-titer biologics in weeks, supporting diverse modalities with robust analytics, scalable productivity, and proven stability across 60+ generations.